predict postop clinic cours autolog tumor-kil activ lung cancer patient fifti patient primari local lung cancer time surgeri abil lymphocyt autolog isol tumor cell assay prognost signific peripher blood lymphocyt patient signific autolog tumor-kil activ assay patient autolog tumor-kil activ tumor free year cur surgeri neg autolog tumor-kil activ month surgeri month surgeri differ surviv curv group signific autolog tumor-kil activ natur killer NK cell activ human myeloid leukemia cell prolifer lymphocyt autolog isol tumor cell mix cultur differ total surviv patient posit result neg result test NK cell activ autolog mix lymphocyte-tumor cultur reaction result autolog tumor-kil activ meaning prognost indic evid immunolog control tumor growth metastasi preliminari data unlik lung cancer patient tumor free month follow-up recurr die diseas studi induct autolog tumor-kil activ surgeri treatment biolog respons modifi clinic outcom patient potenti 